Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pandemic Influenza Disease”

200 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 200 results

Early research (Phase 1)Study completedNCT05397119
What this trial is testing

A Safety and Immunogenicity of Intranasal Nanoemulsion Adjuvanted Recombinant Pandemic Flu Vaccine in Healthy Adults

Who this might be right for
Influenza, Pandemic
BlueWillow Biologics 40
Large-scale testing (Phase 3)Study completedNCT02107807
What this trial is testing

Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Immunosuppressive Conditions *aH5N1:Monovalent H5N1 Influenza Vaccine

Who this might be right for
Influenza, HumanFlu, HumanFlu, Avian+2 more
Seqirus 539
Not applicableStudy completedNCT01046734
What this trial is testing

Virus Shedding and Environmental Deposition of a Novel Influenza Virus

Who this might be right for
Novel (H1N1) Influenza
University of Nottingham 105
Large-scale testing (Phase 3)Study completedNCT01053143
What this trial is testing

Study of Swine-Origin A/H1N1 Influenza Non-Adjuvanted Vaccine in Healthy Adults in India

Who this might be right for
InfluenzaPandemic InfluenzaInfluenza A Virus, H1N1 Subtype
Sanofi Pasteur, a Sanofi Company 100
Large-scale testing (Phase 3)Study completedNCT00319098
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged 18 Years and Above

Who this might be right for
Influenza
GlaxoSmithKline 5,075
Testing effectiveness (Phase 2)Study completedNCT01416571
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Monovalent Pandemic H5N1 Vaccine in Adults

Who this might be right for
Influenza
GlaxoSmithKline 78
Not applicableStudy completedNCT01192737
What this trial is testing

"COhort Study on A/H1N1 FLU During PREGnancy"

Who this might be right for
InfluenzaPregnancy
Institut National de la Santé Et de la Recherche Médicale, France 919
Early research (Phase 1)Study completedNCT01511419
What this trial is testing

Safety Trial of Live Attenuated Influenza (H7N3) Vaccine

Who this might be right for
InfluenzaAvian Influenza
PATH 40
Testing effectiveness (Phase 2)Study completedNCT01640691
What this trial is testing

Immunogenicity and Safety of Pandemic Influenza Vaccine in Healthy Adults

Who this might be right for
Pandemic Influenza
Adimmune Corporation 39
Post-approval studies (Phase 4)Study completedNCT01002040
What this trial is testing

Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Adults With HIV

Who this might be right for
HIV InfectionsH1N1 Influenza
University of British Columbia 150
Post-approval studies (Phase 4)Study completedNCT03023176
What this trial is testing

T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 5, 2013

Who this might be right for
Influenza
Stanford University 20
Testing effectiveness (Phase 2)Study completedNCT00530660
What this trial is testing

Safety and Immunogenicity Study of a Booster Vaccination With a Non-Adjuvanted H5N1 Influenza Vaccine (Follow Up to Study 810501)

Who this might be right for
Influenza
Alachua Government Services, Inc. 141
Post-approval studies (Phase 4)Study completedNCT01730378
What this trial is testing

Immunogenicity and Safety of PrepandrixTM in Korean Subjects Aged 18 to 60 Years Old

Who this might be right for
Influenza
GlaxoSmithKline 131
Post-approval studies (Phase 4)Study completedNCT01499914
What this trial is testing

Cohort Study Evaluating the Clinical Effectiveness, Safety and Immunogenicity to the Pandemic Influenza Vaccination

Who this might be right for
Cystic Fibrosis With Gastrointestinal Manifestation
Assistance Publique - Hôpitaux de Paris 439
Large-scale testing (Phase 3)Study completedNCT00971425
What this trial is testing

Evaluation of the Immune Response and the Safety of a Pandemic Influenza Candidate Vaccine (H1N1)

Who this might be right for
Influenza
GlaxoSmithKline 145
Early research (Phase 1)Study completedNCT00457509
What this trial is testing

Safety and Immunogenicity of H5N1 Adjuvanted, Inactivated, Split-Virion Pandemic Influenza Vaccine in Healthy Adults

Who this might be right for
Pandemic InfluenzaInfluenza A Virus InfectionOrthomyxoviridae Infections
Sanofi Pasteur, a Sanofi Company 251
Early research (Phase 1)Study completedNCT00136331
What this trial is testing

Study of a Pandemic Influenza Vaccine

Who this might be right for
Influenza
Seqirus 400
Testing effectiveness (Phase 2)Study completedNCT00481065
What this trial is testing

Immunogenicity, Safety and Tolerability of Prepandemic Influenza and Seasonal Influenza Vaccine in Adult Subjects

Who this might be right for
PandemicAvian Influenza
Novartis 405
Testing effectiveness (Phase 2)Ended earlyNCT01003418
What this trial is testing

Study to Evaluate Safety and Immunogenicity of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children

Who this might be right for
Influenza
GlaxoSmithKline 8
Testing effectiveness (Phase 2)Study completedNCT01776554
What this trial is testing

Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Children

Who this might be right for
Pandemic H5N1 Influenza
Novartis Vaccines 662
Load More Results